NAVERIS INC.

In News

Caredx to acquire Naveris for up to $260 million - BioWorld News

BioWorld News - Apr 29, 2026

CareDx sharpens precision medicine focus with $260m Naveris acquisition - Yahoo Finance

Yahoo Finance - Apr 29, 2026

A Medicare-covered cancer test is at the center of CareDx's $160M deal - Stock Titan

Stock Titan - Apr 28, 2026

Fenwick Represents CareDX in Pending Acquisition of Naveris - fenwick.com

fenwick.com - Apr 28, 2026

CareDx to acquire oncology diagnostics firm Naveris for $160M - Investing.com

Investing.com - Apr 28, 2026

CareDx to Acquire Naveris to Expand Into Cancer MRD Testing - Yahoo Finance

Yahoo Finance - Apr 29, 2026

Naveris® to Highlight New Publications at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire

Business Wire - Jan 09, 2026

CareDx (NASDAQ: CDNA) boosts 2026 outlook, buys Naveris and launches $100M buyback - Stock Titan

Stock Titan - Apr 28, 2026

Naveris Announces Expanded Medicare Coverage for the NavDx® Test in Identification of Molecular Residual Disease of Anal Squamous Cell Carcinoma - BioSpace

BioSpace - Nov 18, 2025

Naveris Announces Expansion of the NavDx® Test in Anal Cancer Molecular Residual Disease Surveillance - Business Wire

Business Wire - Jan 10, 2025

Naveris Announces Expanded Commercial Payor Coverage for NavDx® Test from Blue Shield of California - BioSpace

BioSpace - Oct 09, 2024

Naveris Announces Expanded Commercial Payor Coverage for NavDx® Test from Blue Shield of California - Business Wire

Business Wire - Oct 09, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment